NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/19/2025
Back to search
Official data from USPTO
CONFORMABLE EMBOLIC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CONFORMABLE EMBOLIC
ST13
US500000098719221Class
5, 10
Filing
98719221
Registration
7908728
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
08/19/2025
Trademark type
Word
Nice classes
5, 10
Filing date
08/27/2024
Registration date
08/19/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/19/2025
Last transaction
08/19/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
First use anywhere
2023-05-00
First use in commerce
2023-05-00
Drawing code
4
Owner type
03
Owner location
Maple Grove, MN, US
Examiner
THOMA, GABRIELLE
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Boston Scientific Scimed, Inc.
Representatives
Lori A. Ruhly Quarles & Brady LLP
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparations for implantable hydrogel-based embolics for treatment of tumors; pharmaceutical preparationsembolization therapy preparations for embolization of tumors; medical preparations for embolization therapy systems for the treatment of hypervascular tumors and blood vessels to stop blood flow and control bleeding and hemorrhaging; medical preparations for vascular embolizationhemorrhage controlperipheral hemostasis; medical preparations used for embolization of vascular lesionstumorstargeted arterial segments of hypervascular tumorscontrol of bleeding due to disease or traumaorgans and segmental embolizations; pharmaceutical preparationsdifferentiated liquid embolic agents for embolization of hypervascular tumors and blood vessels to stop blood flow and control bleeding and hemorrhaging; pharmaceutical preparations for embolization therapy in interventional radiology and oncology in the nature of implants comprised of artificial materialshydrogels
Class 10
Surgical and medical apparatus and instruments for use in general surgery; medical apparatus and instruments for use in embolization surgery; medical devicearterial embolectomy device in the nature of catheters for use in embolectomy; medical device for embolization therapy in interventional radiology and oncology; embolic devices for interventional radiologyinterventional oncology and peripheral hemostasis; medical device for vascular embolization procedures; medical device used for embolization of vascular lesionstumorstargeted arterial segments of hypervascular tumorscontrol of bleeding due to disease or traumaorgans and segmental embolizations; medical devicessyringes and delivery catheters for the delivery of embolic agents delivered through a microcatheter under fluoroscopic control; medical apparatussystem for vascular embolization procedures in the nature of catheters for use in embolectomy; pharmaceutical preparations for medical and surgical purposes in the nature of implantable materials comprised of artificial materialshydrogels; medical preparations for embolization therapy in interventional radiology and oncology in the nature of implants comprised of artificial materialshydrogels; preparations for implantable surgical materials in the nature of implants comprised of artificial materialshydrogels
Publications
History of USPTO decisions and trademark events.
16 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
08/19/2025
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
07/14/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
07/14/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/14/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
07/14/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/14/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/06/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/06/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/06/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/07/2025
GNRT
NON-FINAL ACTION E-MAILED
03/07/2025
CNRT
NON-FINAL ACTION WRITTEN
03/07/2025
DOCK
ASSIGNED TO EXAMINER
03/03/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/17/2025
NWAP
NEW APPLICATION ENTERED
08/27/2024
Continuous trademark protection
Get notified about every new filing that threatens CONFORMABLE EMBOLIC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.